Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2010, Vol. 30 Issue (10): 0-0    DOI:
    
Development of Chimera protein: sFcεRIα/mIg (IgG2)
Download: HTML   PDF(0KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Abstract IgE plays a key role in type I hypersensitivity reactions. The blocks of IgE binding to its high affinity receptor FcεRI can efficiently eliminate allergic reaction. The sFcεRIα/mIg(IgG2)was constructed by gene fusion of the extracellular portion of α subunit of FcεRI receptor with human IgG2 hing region, CH2 and CH3 region. The chimera could be a markedly longer plasma half-life than the soluble extracellular domain. This chimeric protein was produced by transfecting Chinese Hamster Ovary cells (CHO). Following affinity purification, the apparent molecular weight of sFcεRIα/mIg(IgG2), which showed high affinity with human and mouse IgE, was above 170 kDa. This study provided a good foundation for industrialization of this new engineered soluble protein for type I hypersensitivity diseases.

Key wordstype I hypersensitivity diseases IgE sFcεRIα fusion protein     
Received: 29 September 2009      Published: 19 October 2010
Corresponding Authors: Hu Pinliang     E-mail: 327hu@sina.com
Cite this article:

. Development of Chimera protein: sFcεRIα/mIg (IgG2). China Biotechnology, 2010, 30(10): 0-0.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2010/V30/I10/0

No related articles found!